Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Neoplasms × epacadostat × Clear all

Phase

Status

Terminated 2 Withdrawn 1 Unknown 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Parkinson Disease 4, Autosomal Dominant Lewy Body 6 Ovarian Neoplasms 5 Lung Neoplasms 5 Melanoma 4 Head and Neck Neoplasms 4 Carcinoma, Non-Small-Cell Lung 4 Lymphoma 3 Fallopian Tube Neoplasms 3 Stomach Neoplasms 2 Glioblastoma 2 Colorectal Neoplasms 2 Carcinoma, Renal Cell 2 Uveal Melanoma 1 Urinary Bladder Neoplasms 1 Unresectable or Metastatic Solid Tumors 1 Triple Negative Breast Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Prostatic Neoplasms 1 Pancreatic Neoplasms 1 Neoplasms 1 Myelodysplastic Syndromes 1 Microsatellite Instability 1 Leukemia, Myeloid, Acute 1 Hematologic Neoplasms 1 Glioma 1 Esophageal Neoplasms 1 Endometrial Neoplasms 1 Cytopenia 1 Carcinoma, Transitional Cell 1 Carcinoma, Hepatocellular 1

Interventions

Gemcitabine 108 Paclitaxel 92 Carboplatin 79 Bevacizumab 75 pembrolizumab 72 Surveys and Questionnaires 69 Docetaxel 68 Cisplatin 67 Capecitabine 48 Exercise 47 Cyclophosphamide 47 Nivolumab 46 Sorafenib 43 Fluorouracil 43 Irinotecan 42 Pemetrexed 37 Albumin-Bound Paclitaxel 35 Dexamethasone 34 Blood Specimen Collection 34 Radiotherapy 33 Oxaliplatin 31 Leucovorin 31 trametinib 30 Erlotinib Hydrochloride 30 Cetuximab 28 130-nm albumin-bound paclitaxel 28 Therapeutics 26 Ipilimumab 26 Methods 25 Sunitinib 24

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02862457 2022-08-19

MK-3475-434

Merck Sharp & Dohme LLC

Phase 1 Completed

34 enrolled 25 charts

Carcinoma, Non-Small-Cell Lung, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡